179. Williams syndrome
4 clinical trials,   13 drugs   (DrugBank: 7 drugs),   8 drug target genes,   32 drug target pathways

Searched query = "Williams syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2007-006059-37-ES
(EUCTR)
27/05/200919/08/2008ENSAYO CLÍNICO PILOTO, ALEATORIZADO, CONTROLADO, PARALELO, DOBLE-CIEGO, PARA EVALUAR LA EFICACIA Y SEGURIDAD DE LOSARTÁN EN LA REDUCCIÓN DEL ESTRÉS OXIDATIVO Y LA DISMINUCIÓN DE LA TENSIÓN ARTERIAL (TA) EN PACIENTES CON SÍNDROME DE WILLIAMS (SW) Y DOS O MÁS COPIAS DEL GEN NCF1. - LOSARTANWILLIAMSENSAYO CLÍNICO PILOTO, ALEATORIZADO, CONTROLADO, PARALELO, DOBLE-CIEGO, PARA EVALUAR LA EFICACIA Y SEGURIDAD DE LOSARTÁN EN LA REDUCCIÓN DEL ESTRÉS OXIDATIVO Y LA DISMINUCIÓN DE LA TENSIÓN ARTERIAL (TA) EN PACIENTES CON SÍNDROME DE WILLIAMS (SW) Y DOS O MÁS COPIAS DEL GEN NCF1. - LOSARTANWILLIAMS Pacientes con síndrome de Williams con evidencia molecular de microdeleción en 7q11.2. Edad: Niños de más de 5 años y adultos Sexo: ambos sexos estarán representados lo más paritariemente posible Variante molecular de la deleción que confirme la presencia de 2 o más copias del gen NCF1.
MedDRA version: 9.1;Level: LLT;Classification code 10049644;Term: Williams syndrome
Trade Name: COZAAR 50 mg comprimidos recubierto con pelicula
INN or Proposed INN: LOSARTAN POTASICO
Other descriptive name: LOSARTAN POTASSIUM
Programa de Medicina Molecular y Genética, Hospital Vall d´HebronNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
60Spain
2EUCTR2006-005745-11-FR
(EUCTR)
03/04/200806/02/2008Efficacité du minoxidil chez les enfants atteints du syndrome de Williams et Beuren : un essai clinique randomiséEfficacité du minoxidil chez les enfants atteints du syndrome de Williams et Beuren : un essai clinique randomisé Williams syndrome
MedDRA version: 9.1;Level: LLT;Classification code 10049644;Term: Williams syndrome
Trade Name: LONOTEN
INN or Proposed INN: MINOXIDIL
Hospices Civils de LyonNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
France
3NCT00768820
(ClinicalTrials.gov)
May 20017/10/2008The Psychiatric and Cognitive Phenotypes in Velocardiofacial SyndromeThe Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular FactorsVelocardiofacial Syndrome;Williams Syndrome;Fragile X SyndromeDrug: methylphenidate, fluoxetin, risperidoneThe Chaim Sheba Medical CenterNULLRecruitingN/AN/AAll400Phase 4Israel
4NCT00013962
(ClinicalTrials.gov)
September 19983/4/2001Vitamin D Metabolism and the Williams SyndromeVitamin D Metabolism and the Williams SyndromeWilliams SyndromeDrug: Vitamin DNational Center for Research Resources (NCRR)NULLCompleted18 Years50 YearsBothN/AUnited States